Us PEG-modified Drugs Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
PEG-modified Drugs Market was valued at USD 4.5 Billion in 2022 and is projected to reach USD 8.2 Billion by 2030, growing at a CAGR of 8.1% from 2024 to 2030.
The U.S. PEG-modified drugs market is experiencing significant growth, driven by advancements in drug delivery systems and the increasing prevalence of chronic diseases. Polyethylene glycol (PEG) modification, or PEGylation, enhances the pharmacokinetics and pharmacodynamics of therapeutic agents, improving their solubility, stability, and reducing immunogenicity.
In 2023, the global PEG-modified drugs market was valued at approximately USD 12.3 billion and is projected to reach nearly USD 22.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.9%. The U.S. market alone is expected to reach around USD 1,460 million by 2033, with a CAGR of 11.9% from 2024 to 2033. This growth is primarily attributed to the robust biopharmaceutical industry in the United States, which accounted for 44% of global R&D companies and developed 53.4% of all R&D-stage drugs in 2022.
PEGylated drugs are utilized in treating various conditions, including:
Cancer
Chronic kidney diseases
Hepatitis
Multiple sclerosis
Hemophilia
Gastrointestinal disorders
The first PEGylated protein, ADAGEN, was approved by the U.S. Food and Drug Administration (FDA) in March 1990. Since then, the adoption of PEGylation has expanded, with the cancer application segment poised to grow at a CAGR of 13.5% from 2024 to 2033.
From my experience in the pharmaceutical industry, I've observed that PEGylation not only enhances drug efficacy but also improves patient compliance by reducing dosing frequency. This modification technology has become a cornerstone in developing next-generation therapeutics, offering promising solutions for complex diseases.
Moreover, the growing demand for personalized medicine and biologics has further propelled the need for advanced drug delivery systems, positioning PEGylation as a critical component in modern pharmaceutical development. As the industry continues to evolve, the U.S. PEG-modified drugs market is expected to maintain its upward trajectory, driven by innovation and a commitment to improving patient outcomes.
In a related development, the "100 Gigabit Fiber Optic Transceiver Market" has also seen substantial growth, reflecting the broader trend of technological advancements across various sectors.
Get an In-Depth Research Analysis of the Global PEG-modified Drugs Market Size And Forecast [2025-2032]
Â
Merck Sharp & Dohme
Baxalta Inc.
Amgen Inc.
Roche
UCB S.A.
Enzon
Horizon Pharma Plc
Biogen Inc.
Qilu Pharmaceutical Co.
Ltd.
CSPC Baike (Shandong) Biopharmaceutical Co.
Ltd.
Changchun Genescience Pharmaceutical Co.
Ltd.
Xiamen Amoytop Biotech Co.
Ltd.
Jiangsu Hengrui Pharmaceuticals Co.
Ltd.
Hansoh Pharmaceuticak Group Co.
Ltd.
SunBio
Xiamen Sano banger Biotechnology Co.
Ltd
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global PEG-modified Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global PEG-modified Drugs Market
Monomethoxy Poly(ethylene glycol) (MPEG)
Polyethylene glycol (PEG) Derivatives
PEGylated Proteins
PEGylated Nanoparticles
PEG-Modified Antibodies
Oncology
Autoimmune Diseases
Genetic Disorders
Infectious Diseases
Andrology and Gynecology
Intravenous (IV)
Subcutaneous (SC)
Intramuscular (IM)
Oral
Topical
Preclinical Stage
Phase I Clinical Trials
Phase II Clinical Trials
Phase III Clinical Trials
Marketed Products
Pharmaceutical Companies
Biotechnology Firms
Research and Academic Institutions
Contract Research Organizations (CROs)
Hospitals and Clinics
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ PEG-modified Drugs Market Research Analysis
1. Introduction of the Global PEG-modified Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global PEG-modified Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global PEG-modified Drugs Market, By Type
6. Global PEG-modified Drugs Market, By Application
7. Global PEG-modified Drugs Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global PEG-modified Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/